Company News: Pfizer

Share this article:
Pfizer said it will supply its Prevnar 13 pediatric vaccine to impoverished countries for 10 years under the terms of a UNICEF pilot project aimed at fighting pneumococcal disease, the leading cause of vaccine-preventable death for children under 5 globally. Under the terms of an Advance Market Committment agreement, Pfizer has agreed to charge no more than $3.50 per dose for 10 years to meet long-term demand and ensure affordability of the vaccine in developing countries even after the donor contributions are exhausted.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.